Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

SNSE/AMGN stock hub

SNSE/AMGN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SNSE/AMGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

159.6T

Santiago Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SNSE/AMGN

In the news

Latest news · SNSE/AMGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 n/aP50 n/aP75 n/a

Trailing P/E22

P25 n/aP50 n/aP75 n/a

ROE101.3

P25 n/aP50 n/aP75 n/a

ROIC19.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SNSE/AMGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CL
Employees	31,500
Employees Change	1,300%
Employees Change Percent	4.87
Enterprise value	$200T
Exchange	Santiago Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	$159.6T
Price	$333
Price currency	USD
Rev Per Employee	1,098,628,057.14x
Sic	2836
Symbol	snse/AMGN
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.54%
EV Earnings	27.57x
EV/EBIT	18.47x
EV/EBITDA	13.06x
EV/FCF	25.02x
EV/Sales	6.03x
FCF yield	5.01%
Forward P/E	14.61x
P/B ratio	18.68x
P/E ratio	22.01x
P/S ratio	4.61x
PE Ratio10 Y	25.07x
PE Ratio3 Y	28.82x
PE Ratio5 Y	25.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.63%
EBITDA Margin	45.45%
FCF margin	23.1%
Gross margin	71.44%
Gross Profit	$24.7T
Gross Profit Growth	12.82%
Gross Profit Growth Q	10.41%
Gross Profit Growth3 Y	10.66%
Gross Profit Growth5 Y	6.92%
Net Income	$7.3T
Net Income Growth	31.47%
Net Income Growth Q	5.15%
Net Income Growth3 Y	-0.5%
Net Income Growth5 Y	1.94%
Pretax Margin	24.41%
Profit Margin	20.96%
Profit Per Employee	$230.2M
ROA	8.35
Roa5y	8.22
ROCE	17.98
ROE	101.3
Roe5y	101.8
ROIC	19.05
Roic5y	20.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.16%
Cagr1y	35.19%
Cagr3y	13.17%
Cagr5y	9%
Div CAGR10	14.64%
Div CAGR3	9.4%
Div CAGR5	11.95%
EPS Growth	31.3
EPS Growth Q	4.38
EPS Growth3 Y	-0.8
EPS Growth5 Y	3.54
FCF Growth	-21.24%
FCF Growth Q	50.71%
FCF Growth3 Y	4.51%
FCF Growth5 Y	-2.65%
OCF Growth	-11.78%
OCF Growth Q	57.37%
OCF Growth10 Y	0.57%
OCF Growth3 Y	7.65%
OCF Growth5 Y	0.55%
Revenue Growth	9.07x
Revenue Growth Q	5.76x
Revenue Growth3 Y	12.43x
Revenue Growth5 Y	8.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.41
Assets	$86T
Cash	$11.2T
Current Assets	$28.1T
Current Liabilities	$22.2T
Debt	$53.3T
Debt EBITDA	$3.34
Debt Equity	$6.24
Debt FCF	$6.67
Equity	$8.5T
Interest Coverage	3.92
Liabilities	$77.5T
Long Term Assets	$58T
Long Term Liabilities	$55.2T
Net Cash	$-42.1T
Net Cash By Market Cap	$-26.38
Net Debt EBITDA	$2.68
Net Debt Equity	$4.93
Net Debt FCF	$5.27
Tangible Book Value	$-28.7T
Tangible Book Value Per Share	$-53,170

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.26
Inventory Turnover	1.65
Net Working Capital	$-75.3B
Quick ratio	0.85
Working Capital	$6.1T
Working Capital Turnover	$6,629

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%
Dividend Growth	4.8%
Dividend Growth Years	13%
Dividend per share	$8,965
Dividend Years	14
Dividend Yield	2,693.97%
Ex Div Date	2026-02-13
Last Dividend	$2,177
Payout Frequency	Quarterly
Payout Ratio	66.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	163.22%
1Y total return	35.16%
200-day SMA	291.6
3Y total return	44.96%
50-day SMA	332.8
50-day SMA vs 200-day SMA	50over200
5Y total return	53.87%
All Time High	377.1
All Time High Change	-11.74%
All Time High Date	2026-03-10
All Time Low	110.4
All Time Low Change	201.33%
All Time Low Date	2015-07-01
ATR	0.34
High52	377.1
High52 Date	2026-03-10
High52ch	-11.74%
Low52	246.2
Low52 Date	2025-05-15
Low52ch	35.16%
Ma50ch	0%
Price vs 200-day SMA	14.11%
RSI	100
RSI Monthly	100
RSI Weekly	100
Sharpe ratio	0.99x
Total Return	2,693.88%
Tr YTD	0.76
Tr3m	0.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$11.3T
Operating Income Growth	18.32
Operating Income Growth Q	24.43
Operating Income Growth3 Y	8.22
Operating Income Growth5 Y	5.8
Operating margin	32.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	538,255,159%
Net Borrowing	14,260,640,000
Shares Insiders	0.17%
Shares Institutions	81.87%
Shares Qo Q	0.18%
Shares Yo Y	0.09%
Short Ratio	4.77

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$7.5T
Average Volume	0x
Bv Per Share	15,832.4
CAPEX	$-2T
Ch10y	93.01
Ch1y	30.42
Ch3y	30.42
Ch5y	30.42
Ch6m	30.42
Change	0%
Close	332.8
Depreciation Amortization	4,253,235,880,000
Earnings Date	2026-04-30
EBIT	$11.3T
EBITDA	$15.7T
EPS	$13,360
F Score	8
FCF	$8T
FCF EV Yield	4x
Financing CF	-4,942,763,640,000
Fiscal Year End	December
Founded	1,980
Goodwill	16,643,949,460,000
Graham Number	77.86053
Graham Upside	-76.6
Income Tax	$1.2T
Investing CF	-2,056,695,480,000
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	$75.61
Lynch Upside	-77.28
Ma150	303.8
Ma150ch	9.54%
Ma20	332.8
Ma20ch	0%
Net CF	3,001,362,120,000
Next Earnings Date	2026-08-04
P FCF Ratio	19.97
P OCF Ratio	15.96
Payment Date	2026-03-06
Ppne	7,322,838,640,000
Price Date	2026-05-07
Price EBITDA	$10.15
Relative Volume	1,000x
Revenue	34,606,783,800,000x
SBC By Revenue	1.3x
Share Based Comp	450,018,360,000
Tax By Revenue	3.46x
Tax Rate	14.16%
Tr6m	32.65%
Z Score	1.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SNSE/AMGN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2694.0%

$8965 annual per share

Payout ratio

+66.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+12.0%

13 consecutive years of growth

Total shareholder yield

+2693.9%

Next ex-dividend date: 2026-02-13

Performance

SNSE/AMGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SNSE/AMGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+81.9%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SNSE/AMGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

100.0

Above 70: short-term overbought

Price vs 200-day MA

+14.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.99

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SNSE/AMGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current snse/AMGN stock rating?

snse/AMGN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full snse/AMGN analysis?

The full report lives at /stocks/snse/AMGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for snse/AMGN?

The latest report frames snse/AMGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the snse/AMGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.